Cologuard is shown to be effective. In a clinical study of 10,000 participants ages 50-84 years old, of average risk for colorectal cancer, Cologuard found 92% of cancer.1 More about how Cologuard is effective
1. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-1297.